drugset / Trial / NCT03105986
A Phase 1 Study to Evaluate the Effect of the Organic Anion Transporter Inhibitor Probenecid on the Pharmacokinetics of JNJ-64041575 in Healthy Adults
RandomizedCrossoverOpen-labelOther
Summary
The purpose of this study is to evaluate the effect of multiple-dose administration of probenecid on the pharmacokinetics of JNJ-63549109 and JNJ-64167896 after a single dose of JNJ-64041575 in healthy adult participants.
Timeline
- Start
- 2017-04-05
- Primary completion
- 2017-06-16
- Completion
- 2017-06-16
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | JNJ-64041575 | Unknown | 1000 mg | Oral |
| Subject | Probenecid | Small molecule | 500 mg | Oral |
Indications
No indication recorded.